Abstract: The disclosures herein relate to novel compounds of formula (1) and salts thereof, wherein V; W; X; Y; Z; R1; R2; R3; R4 and R5 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.

Abstract: Techniques are disclosed for provisioning and managing resources within a cloud infrastructure of a first cloud service provider for cloud services offered by a second cloud service provider. Cross-cloud services can be provisioned and managed by and between private clouds of cloud service providers. The techniques include receiving a request for a cloud service by a component of a first private cloud within a first cloud environment and from a component of a second private cloud within a second cloud environment. The techniques further include the component of the first private cloud performing one or more operations to establish network connectivity prerequisites for network connectivity between the first private cloud and the second private cloud and causing one or more components of the first private cloud to provision the cloud service in the second private cloud.

Abstract: Techniques are disclosed for provisioning a cloud service of a first cloud service provider using a control plane of a second cloud service provider. The techniques include detecting that a request for a cloud service provided by the first cloud service provider has been received from the second cloud environment of a second cloud service provider different from the first cloud service provider. The techniques further include, after detecting that the request for the cloud service has been received, provisioning a first set of resources within the first cloud environment and linking the first set of resources to a second set of resources within the second cloud environment. Linking the first set of resources to the second set of resources enables data pertaining to the cloud service to be transferred from the second cloud environment to the first cloud environment.

Abstract: Described herein is an absorbent article including (a) an absorbent core, a first nonwoven material, a second nonwoven material, and a bond area; and (b) a polymeric filler composition disposed within the bond area. The polymeric filler composition has less than 5% of a tackifier. The polymeric filler composition is chosen from a propylene butene copolymer, a polypropylene homopolymer, a propylene ethylene copolymer, and mixtures thereof. The polymeric filler composition has a Tensile Strength at Yield of from about 0.5 MPa to about 10 MPa.

Abstract: One example method for controlling presentations in video conferences includes displaying, by a video conference application executing on a first client device, a first slide of a plurality of slides in a slide presentation as part of a visual display of a video conference on the first client device, receiving, by the video conference application executing on the first client device from the video conference application executing on a second client device, a command to display a second slide, wherein the command is issued by a first user of a plurality of users of the video conferencing application authorized to control the slide presentation; and displaying, by the video conference application executing on the first client, the second slide in response to receiving the command.

Abstract: A home cost analysis server for executing a customized home search may include a processor programmed to define a user budget constraint, receive a list of available homes, and determine an initial monthly cost for each home. The processor may also identify one or more additional home costs based on historical insurance claim data. The processor may also display available homes that satisfy the user budget constraint.

Abstract: Disclosed herein are novel microbial polycultures of two or more cell strains, capable of producinges, flavonoids, and anthocyanidin-3-O-glucosides, and methods of use thereof. Also disclosed is a microbial cell capable of producing phenylpropanoic acids, and methods of use thereof.

Abstract: A method of modeling that allows for kinetic parameters to be extracted from DCE-MRIs performed with the temporal resolutions commonly used in the clinical setting is described herein. The kinetic parameters can be combined with analytic models of cancers to create predictors of disease recurrence.

Abstract: In an embodiment, a polyurethane comprises the residues of i. an aliphatic diisocyanate, ii. an aliphatic diol comprising a poly(ethylene oxide) moiety, iii. an aliphatic diol comprising a polycarbonate moiety, and iv. a chain extender, wherein the polyurethane has a melting temperature of 140° C. or less and has a weight average molecular weight of from 100,000 to 500,000 g/mol. In an embodiment, the polyurethane is substantially devoid of catalyst. In an embodiment, the polyurethane is formed by reactive extrusion. In an embodiment, a medical device comprises the polyurethane and a bioactive agent. The medical devices, methods, and polyurethanes may exhibit benefits in end-product biostability, drug release profile, health and safety, and processing speed or reproducibility.

Abstract: Wireless-enabled kiosk systems and associated methods for recycling and performing other processes with mobile phones and other electronic devices are described herein. In various embodiments, the present technology includes systems and methods for wirelessly connecting a consumer-operated kiosk with an electronic device to facilitate processing (e.g., purchasing) the device. In some embodiments, the present technology includes using a wireless link to identify a device, evaluate a device, resolve device issues to enable purchase of the device, locate a device, etc. Various other aspects of the present technology are described herein.

Abstract: Methods and compositions are provided for making and using capture tags attached to a target polymer in a dual nanopore sequencing system. In alternative embodiments, provided are systems, and products of manufacture and kits have contained therein, or comprise, a system as provided herein, wherein the system can comprise: a dual nanopore device; and a tagged target polymer comprising a capture tag at a first distal end and a capture tag at a second distal end, wherein the capture tag comprises a single-stranded tail.

Abstract: Systems and associated methods for recycling and performing other processes with consumer electronic devices are described herein. In various embodiments, the present technology includes systems and methods for identifying and evaluating an electronic device to facilitate processing (e.g., purchasing) the device. In some embodiments, the present technology includes a self-service evaluation apparatus and a cashier terminal that identifies and evaluates a device and that facilitates purchase and recycling of the device. Various other aspects of the present technology are described herein.

Abstract: A medical device system may include transducers and a structure on which the transducers are located. The structure may include at least a first portion of each elongate member of a plurality of elongate members. Each respective set of a plurality of sets of one or more of the transducers may be located on a respective one of the plurality of elongate members. The structure may be selectively moveable between a delivery configuration in which the structure is sized to be percutaneously deliverable to a bodily cavity and a deployed configuration in which the structure is sized too large to be percutaneously deliverable to the bodily cavity. The second portion of each elongate member of the plurality of elongate members may be arranged in a helical configuration or a twisted, non-helical configuration including at least 360 degrees of rotation when the structure is in the delivery configuration.

Abstract: A densified carbon-carbon composite material exhibits superior strength and toughness, relative to low density carbon-carbon composites. The process densification of a set of carbon fibers with a non-fibrous carbon material, resulting in a precursor carbon matrix, stabilizing the precursor carbon matrix, resulting in a stabilized carbon matrix, and densifying the stabilized carbon matrix using a field assisted sintering technology (FAST) process, resulting in the high density carbon-carbon composite material.

Abstract: Described herein are technologies that provide an element of security related to file system operations. Individual nodes in a file system, such as a directory or a file, can be associated with information that describes how to handle letter case when a file name included in a file system operation request is used to locate a file in the file system. For example, a case sensitive designation associated with a directory can require a case sensitive match between a file name included in a request and a file name included in the directory, in order to perform the requested file system operation. In another example, a case preferring designation associated with a directory first checks for a case sensitive match between file names. If a case sensitive match does not exist, then a case insensitive match between the file names can be used to perform the requested file system operation.

Abstract: A cryogenic vessel includes an outer vessel at least partially formed from a reinforced concrete. The cryogenic vessel further includes an inner vessel disposed in the outer vessel. The cryogenic vessel further includes an airtight liner disposed between the inner vessel and the outer vessel, wherein the liner is anchored to the outer vessel. The cryogenic vessel further includes a vacuum space disposed between the inner vessel and the liner, wherein an insulation material is disposed in the vacuum space.

Abstract: Provided herein is an engagement and care support platform (“ECSP”) computer system including at least one processor in communication with at least one memory device for facilitating senior user engagement. The processor is programmed to: (i) register a user through an application, (ii) register a caregiver associated with the user through the application, (iii) generate a senior profile based upon user personal and scheduling data, (iv) build a daily interactive user interface that reflects the senior profile, (v) display the daily interactive user interface at a first client device associated with the user, (vi) cause the first client device to initiate a daily interaction prompt to the user, (vii) determine whether any user interaction was received in response to the daily interaction prompt, and (viii) transmit a daily update message to a second client device associated with the caregiver, including an indication of whether any user interaction was received.

Abstract: Provided herein are polynucleotides and CRISPR effector proteins configured to be covalently bound together in a CRISPR complex. The polynucleotides can be further modified to modulate the activity of the CRISPR complex. Modification of the polynucleotide and CRISPR effector protein can be used to improve the efficacy of target binding and/or cleavage.

Abstract: A method of determining antibiotic resistance of bacteria includes dividing a sample including the bacteria into a plurality of sub-samples, mixing labeling: agents with each of the plurality of sub-samples. Each of the labeling agents is detectible via a detection system including a sensor to detect photoacoustic waves. The labeling: agents are further active to selectively bind with the bacteria. The method further includes applying an antibiotic to one or more of the plurality of sub-samples and not to one or more others of the plurality of sub-samples, characterizing at least one of the sub-samples to which the antibiotic has been applied and at least one of the sub-samples to which no antibiotic has been applied after a determined period of time via the detection system, and determining antibiotic resistance of the bacteria on the basis of the characterization via the detection system.

Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.